Project Summary/Abstract
The overarching objective of this project is to develop an advanced computational super-resolution model to
enhance the throughput and resolution of chemical imaging. Chemical imaging, which includes advanced
techniques such as stimulated Raman scattering (SRS) microscopy, holds immense potential in intraoperative
cancer detection. This is due to its ability to generate intrinsic molecular contrasts without tissue processing or
labeling, which can improve the accuracy and speed of intraoperative diagnosis. Such improvement is crucial to
better patient outcomes by providing near real-time feedback to the surgeon and reducing the risk of leftover
cancerous tissues. However, existing chemical imaging techniques grapple with an inherent limitation – the
tradeoff between spatial resolution and imaging field of view, resulting in low imaging throughput and prolonged
imaging durations for larger tissue samples. For other applications involving live cell imaging, the limited
resolution of SRS (> 300nm) hinders visualization of subcellular organelles and fine structures.
Computational super-resolution, bolstered by advancements in artificial intelligence, can address these
challenges by transforming low-resolution images into high-resolution versions. This has been achieved with the
Convolutional Neural Network and the Generative Adversarial Network. However, super-resolution chemical
imaging is scarce. There are no datasets available for super-resolution training. It is also unclear whether existing
super-resolution microscopy techniques could work for chemical images due to vast differences in imaging
contrasts. Here we propose to develop a new super-resolution technique ChemDiffuse that is based on the
diffusion-based deep generative network. Diffusion-based models are widely used in popular image-generation
tools such as Midjourney and DALL-E. While superior in stability and image quality to CNN and GAN models,
they need extensive training data. Leveraging on our recent progress in image augmentation and a new diffusion
model for 2D and 3D data, we will develop the ChemDiffuse model to significantly improve SRS imaging
throughput and resolution. We aim to test the application of the ChemDiffuse super-resolution model in two
different areas: 1. Fast gigapixel SRS imaging of tissue at submicron resolution for pathology application. We
will use mouse brain tissue as our test system to train the ChemDiffuse model to enable fast 3D SRS imaging at
10 million pixels/sec, a 40-fold improvement in lateral dimension, and another 10-fold improvement in axial
dimensional. Such improvement is crucial for intraoperative stimulated Raman histology of large tissues. 2.
Label-free SRS imaging of live cell organelles at 150 nm resolution. We will train the super-resolution model to
enable 2-fold resolution enhancement with regular SRS imaging, an improvement that will allow unprecedented
label-free tracking of multiple organelles and single cell analysis for a wide range of drug discovery applications.
Though our focus is on SRS imaging, this methodology can benefit various other chemical imaging techniques,
including Raman microscopy, IR imaging, transient absorption microscopy, and photothermal microscopy, etc.
Public Health Relevance Statement
Public Health Relevance/Narrative
Chemical imaging holds tremendous promise in intraoperative cancer diagnosis and personalized drug
screening. However, the inherent tradeoff between resolution and field of view is a major challenge to its various
biomedical applications. We will develop new deep-learning algorithms to break the tradeoff and enable large-
area, high-resolution chemical imaging of any biological samples.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
605799469
UEI
HD1WMN6945W6
Project Start Date
01-August-2024
Project End Date
31-May-2026
Budget Start Date
01-August-2024
Budget End Date
31-May-2025
Project Funding Information for 2024
Total Funding
$196,182
Direct Costs
$135,000
Indirect Costs
$61,182
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$196,182
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R21EB036205-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R21EB036205-01
Patents
No Patents information available for 1R21EB036205-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R21EB036205-01
Clinical Studies
No Clinical Studies information available for 1R21EB036205-01
News and More
Related News Releases
No news release information available for 1R21EB036205-01
History
No Historical information available for 1R21EB036205-01
Similar Projects
No Similar Projects information available for 1R21EB036205-01